Medicare Enrolled
Dr. Charles Loewe, MD
Gastroenterology · Sarasota, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Loewe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Loewe?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Loewe
Dr. Charles Loewe is a gastroenterology specialist in Sarasota, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Loewe performed 15,411 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Loewe received a total of $98,595 from 58 pharmaceutical and/or device companies across 820 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Loewe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 2% volume in FL
$98,595 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 43998 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗15,411
Medicare services
Top 2% in FL for gastroenterology
Not available
Unique patients (not deduplicated)
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
14,100 | $17 | $43 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
218 | $94 | $256 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
188 | $208 | $523 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
146 | $56 | $282 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
135 | $20 | $410 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $130 | $363 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $128 | $337 |
| New patient office visit, complex (60-74 min) | 82 | $172 | $447 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
63 | $53 | $176 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
49 | $50 | $133 |
| Radiologist review of bile duct tube placement imaging A radiologist reviews images taken during the placement of a tube into the bile duct using an endoscope. |
43 | $18 | $324 |
| Endoscopic removal of bile or pancreatic duct stone A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts. |
41 | $156 | $745 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
33 | $70 | $235 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $78 | $227 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
21 | $87 | $315 |
| Endoscopic removal of esophagus, stomach, or small bowel polyps This procedure uses an endoscope and a mechanical snare to remove polyps or growths from the esophagus, stomach, or upper small bowel. |
19 | $127 | $401 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
19 | $209 | $554 |
| Endoscopic incision of pancreatic outlet A procedure where a flexible endoscope is used to make an incision in the pancreatic outlet. |
17 | $57 | $733 |
| Pancreatic or bile duct stent insertion A flexible endoscope is used to place a stent into the pancreatic or bile duct to keep it open. |
14 | $327 | $948 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
11 | $110 | $339 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
91.9% high complexity
2.7% medium
5.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$98,595
Total received (2018-2024)
Avg $14,085/year across 7 years
Top 2% in FL for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
820
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$58,532
2023
$9,408
2022
$4,413
2021
$1,604
2020
$1,151
2019
$14,468
2018
$9,019
Payments by company (2024)
Phathom Pharmaceuticals, Inc.
$51,007
Intercept Pharmaceuticals, Inc.
$4,088
Janssen Biotech, Inc.
$710
ABBVIE INC.
$520
PFIZER INC.
$281
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$241
Takeda Pharmaceuticals U.S.A., Inc.
$168
AIMMUNE THERAPEUTICS, INC.
$165
Boston Scientific Corporation
$143
Gilead Sciences, Inc.
$139
GENZYME CORPORATION
$126
FUJIFILM Healthcare Americas Corporation
$118
QOL Medical, LLC
$107
Lilly USA, LLC
$106
IRONWOOD PHARMACEUTICALS, INC
$82
3-D Matrix, Inc.
$76
Mallinckrodt Hospital Products Inc.
$68
Celgene Corporation
$54
Regeneron Healthcare Solutions, Inc.
$51
Ardelyx, Inc.
$49
Celltrion USA Inc.
$49
Fresenius Kabi USA, LLC
$46
Pharmacosmos Therapeutics Inc.
$24
Madrigal Pharmaceuticals
$24
E.R. Squibb & Sons, L.L.C.
$24
Ipsen Biopharmaceuticals, Inc
$22
Braintree Laboratories, Inc.
$22
Merck Sharp & Dohme LLC
$20
Top 3 companies account for 95.3% of 2024 payments
All-time payments by company (2018-2024) ›
Phathom Pharmaceuticals, Inc.
$51,007
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19,038
INTERCEPT PHARMACEUTICALS, INC.
$7,324
Intercept Pharmaceuticals, Inc.
$4,329
Janssen Biotech, Inc.
$2,839
ABBVIE INC.
$2,351
PFIZER INC.
$1,308
Takeda Pharmaceuticals U.S.A., Inc.
$1,212
Shionogi Inc
$896
Boston Scientific Corporation
$829
Celgene Corporation
$586
GENZYME CORPORATION
$493
Biogen, Inc.
$450
QOL Medical, LLC
$399
Ironwood Pharmaceuticals, Inc
$391
Allergan Inc.
$376
AbbVie, Inc.
$327
AbbVie Inc.
$319
Merck Sharp & Dohme Corporation
$318
Ethicon US, LLC
$266
E.R. Squibb & Sons, L.L.C.
$259
RedHill Biopharma Inc.
$257
Allergan, Inc.
$220
Regeneron Healthcare Solutions, Inc.
$202
Gilead Sciences, Inc.
$200
Janssen Scientific Affairs, LLC
$183
AIMMUNE THERAPEUTICS, INC.
$180
Covidien LP
$180
Nestle HealthCare Nutrition Inc.
$143
Dova Pharmaceuticals
$140
Ardelyx, Inc.
$125
FUJIFILM Healthcare Americas Corporation
$118
Lilly USA, LLC
$106
Daiichi Sankyo Inc.
$102
Merck Sharp & Dohme LLC
$100
FUJIFILM Medical Systems USA, Inc.
$96
Fresenius Kabi USA, LLC
$92
IRONWOOD PHARMACEUTICALS, INC
$82
3-D Matrix, Inc.
$76
Pharmacosmos Therapeutics Inc.
$71
UCB, Inc.
$69
Mallinckrodt Hospital Products Inc.
$68
EVOKE PHARMA, INC.
$59
Palette Life Sciences, Inc.
$59
Braintree Laboratories, Inc.
$54
Celltrion USA Inc.
$49
Ferring Pharmaceuticals Inc.
$47
VIVUS LLC
$35
Madrigal Pharmaceuticals
$24
Ipsen Biopharmaceuticals, Inc
$22
Alfasigma USA, Inc.
$19
Pinnacle Biologics, Inc
$18
Aries Pharmaceuticals, Inc.
$17
Shire North American Group Inc
$15
NESTLE HEALTHCARE NUTRITION INC.
$13
GI Supply, Inc.
$13
Cook Medical LLC
$12
BioDelivery Sciences International, Inc.
$12
Top 3 companies account for 78.5% of all-time payments
Associated products mentioned in payments ›
ACQUIRE · AGILE ESOPHAGEAL · APRISO · Acquire · Aemcolo · Amitiza · AutoCap RX · BUNAVAIL 2.1 mg 30-count box · Bylvay · CAPTIVATOR COLD · CLENPIQ · CRE PRO · CREON · Certus 140 · Cimzia · Cook Medical Fusion · Creon · DIFICID · DUPIXENT · Doptelet · ELEVIEW · ENTYVIO · ESD - Core Endoscopy · EXALT MODEL D CONTROLLER · EXALT Model D · Entyvio · FUJIFILM · GATTEX · GENERAL BILIARY DEVICES · GENERAL HEMOSTASIS · GIMOTI · General - GI Dilatation · HUMIRA · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · LINX Reflux Management System · LINZESS · Linzess · Livdelzi · MAVYRET · MONOFERRIC · MOTEGRITY · Mavyret · Motegrity · Movantik · Mulpleta · OCALIVA · OMVOH · ORISE · PANCREAZE · Photofrin · PillCam · RELISTOR · REMICADE · RESMETIROM · RESOLUTION CLIP · RINVOQ · SKYRIZI · SOLESTA · SPYGLASS · SPYGLASS RETRIEVAL BASKET · STELARA · SUCRAID · SUFLAVE · SUTAB · SpyGlass · Sucraid · TERLIVAZ · TREMFYA · TRULANCE · TYSABRI · Talicia · UCERIS · UCERIS TABLETS · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · VPRIV · WATCHMAN Access System · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
62
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
SARASOTA MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Loewe is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Loewe experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Loewe performed 14,100 vedolizumab infusion (entyvio) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Loewe receive payments from pharmaceutical companies?
Yes. Dr. Loewe received a total of $98,595 from 58 companies across 820 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Loewe's costs compare to other gastroenterologists in Sarasota?
Dr. Loewe's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Loewe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Sarasota
Browse gastroenterologists in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in FL
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in FL
Which FL gastroenterologists receive the most from drug and device companies.
By company
Phathom Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Phathom Pharmaceuticals, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
INTERCEPT PHARMACEUTICALS, INC. Payments to Doctors
See all physicians who received payments from INTERCEPT PHARMACEUTICALS, INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology